Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Dutch Healthcare Institute implemented the MedTech Horizon Scan

29 Jan 2024

Dutch Healthcare Institute (ZIN) implemented the MedTech Horizon Scan to gain a better insight into the arrival of medical technological innovations (MedTech). The objective of the MedTech Horizon Scan is to map the rise of high-risk medical technology for ZIN and all parties in the field. It concerns medical technologies and digital applications that are expected to be seen in healthcare in the next 1-3 years.

The Dutch Healthcare Institute (ZIN) will also use this information for its agenda, such as the further development of basic health insurance package and the clarification of package issues.

One of the reports published by ZIN under MedTech Horizon Scan concerns diabetes care

See more information in Dutch here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.